Cardinal Health CEO Michael C. Kaufmann Sells 50,216 Shares (CAH)
Cardinal Health (NYSE:CAH) CEO Michael C. Kaufmann unloaded 50,216 shares of the stock on the open market in a transaction dated Thursday, September 4th. The stock was sold at an average price of $74.95, for a total transaction of $3,763,689.20. Following the transaction, the chief executive officer now directly owns 118,576 shares of the company’s stock, valued at approximately $8,887,271. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Cardinal Health (NYSE:CAH) traded up 0.59% on Friday, hitting $74.74. 152,485 shares of the company’s stock traded hands. Cardinal Health has a 52 week low of $49.65 and a 52 week high of $75.00. The stock has a 50-day moving average of $72.0 and a 200-day moving average of $70.0. The company has a market cap of $25.162 billion and a price-to-earnings ratio of 21.99.
Cardinal Health (NYSE:CAH) last released its earnings data on Monday, August 4th. The company reported $0.83 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter in the previous year, the company posted $0.79 earnings per share. The company’s revenue for the quarter was down 9.9% on a year-over-year basis. On average, analysts predict that Cardinal Health will post $4.22 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a dividend of $0.3425 per share. This represents a $1.37 annualized dividend and a dividend yield of 1.84%. The ex-dividend date is Monday, September 29th.
A number of research firms have recently commented on CAH. Analysts at Argus reiterated a “buy” rating on shares of Cardinal Health in a research note on Monday, August 18th. They now have a $71.43 price target on the stock, down previously from $83.00. Separately, analysts at Barclays reiterated an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $82.00 price target on the stock, up previously from $77.00. Finally, analysts at Credit Suisse reiterated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $80.00 price target on the stock, up previously from $76.00. Three research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $77.93.
Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.